Provision of high quality monoclonal antibodies
Updated | 04/10/2011 15:03Updated | 13/12/2010 11:11
Updated | 13/12/2010 11:11
A Company focused on the discovery, development and commercialization of monoclonal antibodies for the diagnosis and treatment of cancer and other diseases with unmet medical need.
Updated | 07/12/2010 16:04Updated | 27/04/2010 16:04
MediaPharma s.r.l. P.IVA.: IT 02282760699 | Rea di Chieti: 166532
The information provided on www.mediapharma.it is designed to complement, not replace, the relationship between a patient and his/her own physician.